Pipeline Momentum: Market participants on social media are highlighting SELLAS Life Sciences Group's recent share price surge to around $12 amid anticipation of upcoming clinical data releases. Analysts have pointed to potential price targets of $25 to $30 in a successful trial scenario, reflecting broad optimism about the company's dual-platform pipeline.
Acquisition Buzz: Discussions also center on rumors of a possible buyout valued at $15 billion or more, with some noting the stock's 52-week range and market capitalization near $2 billion as signs of growing interest. Traders emphasize the need for disciplined risk management amid the volatility in biotech names.
Sentiment Shift: Overall commentary reflects a cautiously positive tone following earlier pullbacks, with references to heavy volume and moving average levels underscoring short-term trading dynamics without committing to specific outcomes.
Note: This discussion summary was generated from an AI condensation of post data.
SELLAS Life Sciences Group Hedge Fund Activity
We have seen 109 institutional investors add shares of SELLAS Life Sciences Group stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STATE STREET CORP added 6,208,185 shares (+283.7%) to their portfolio in Q1 2026, for an estimated $26,260,622
- BLACKROCK, INC. added 4,657,356 shares (+61.8%) to their portfolio in Q1 2026, for an estimated $19,700,615
- JONES FINANCIAL COMPANIES LLLP added 1,245,834 shares (+290.2%) to their portfolio in Q1 2026, for an estimated $5,269,877
- MILLENNIUM MANAGEMENT LLC removed 1,228,325 shares (-88.5%) from their portfolio in Q1 2026, for an estimated $5,195,814
- GEODE CAPITAL MANAGEMENT, LLC added 835,269 shares (+27.1%) to their portfolio in Q1 2026, for an estimated $3,533,187
- UBS GROUP AG added 696,692 shares (+1429.8%) to their portfolio in Q1 2026, for an estimated $2,947,007
- MARSHALL WACE, LLP added 696,494 shares (+52.0%) to their portfolio in Q1 2026, for an estimated $2,946,169
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
